Focus Fund
  • Home
  • About
    • Mission & Values
    • Investment Strategy
  • Team
  • News
  • Contact
Select Page

Esperance Pharmaceuticals Names Brett Giroir MD to Board of Directors

by rpadmin | Jun 13, 2019 | PR Newswire

PRNewswire  |  3/17/2016

Esperance Announces Strategic Alliance with MD Anderson Cancer Center

by rpadmin | Jun 13, 2019 | PR Newswire, Uncategorized

PR Newswire  |  8/24/2015

Sources

  • Baylor College of Medicine
  • EndPoint News
  • Houston Business Journal
  • MD Anderson News
  • PR Newswire
  • Salarius Pharmaceuticals
  • TMC News
  • Uncategorized
  • Xconomy

At The Focus Fund, we invest in promising technologies that are close to being tested in humans. Our objective is to leverage MD Anderson resources to provide investors with superior risk-adjusted returns.

At The Focus Fund, we invest in promising technologies that are close to being tested in humans. Our objective is to leverage MD Anderson resources to provide investors with superior risk-adjusted returns.

Texas Medical Center

2450 Holcombe Boulevard
Houston, TX 77021

Shreveport

2031 Kings Highway
Shreveport, LA 71103

Pages

  • Home
  • About
  • News
  • Contact
  • Team

Copyright © 2020 Focus Fund|Developed by RP Agency